Document Classification

Section Type: RESULTS

Text: At 6 and 12 months of therapy, carvedilol plus standard treatment was associated with significant decreases from baseline in SOD (2516 [126] and 2550 [118], respectively, vs 2781 [116] U/g Hb ; both, P < 0. 001) and GR (4. 7 [0. 3] and 4. 1 [0. 2], respectively, vs 5. 3 [0. 2] micromol NADPH/min/g Hb ; P < 0. 05 and P < 0. 001) and increased CAT (16. 9 [1. 0] and 16. 4 [0. 7], respectively, vs 12. 7 [0. 9] U/g Hb ; both, P < 0. 001).